FDA To Launch New Research Project Focused On Real-World Evidence To Learn More About COVID-19
- May 20, 2020
Bloomberg Law (5/19, Lee, Subscription Publication) reports the Food and Drug Administration (FDA) “said Tuesday it’s pairing up with the data company Aetion to research Covid-19 complications and what types of medicines virus patients are taking, which could help researchers learn more about which treatments are effective.” FDA Principal Deputy Commissioner of Food and Drugs Amy Abernethy said in a statement that the partnership with Aetion will add to the data the FDA has already gained through the use of its internal drug monitoring system called Sentinel to “contribute to the scientific evaluation of potential diagnostics and interventions for COVID-19,”